July 22, 2019 Price forecast | 2 weeks: 5.95% | 1 month: 6.38% | 3 months: 6.02%


FTSV stock forecast

Our latest prediction for Forty Seven, Inc.'s stock price was made on the July 22, 2019 when the stock price was at 8.81$.

In the short term (2weeks), FTSV's stock price should outperform the market by 5.95%. During that period the price should oscillate between -7.96% and +15.02%.

In the medium term (3months), FTSV's stock price should outperform the market by 6.02%. During that period the price should oscillate between -19.55% and +36.03%.


About Forty Seven, Inc.

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.47$ per share.

The book value per share is 3.60$

Forty Seven, Inc. website


Three months stock forecastJuly 22, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -88M - -85M -0.47 - - 31M 3.60 -81M - -81M